ovarian cancer peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015723
A cancer vaccine comprised of synthetic peptides corresponding to naturally-occurring peptides derived from ovarian cancer cell antigens. Ovarian cancer peptide vaccine may elicit a cytotoxic T-cell response against tumor cells expressing the related ovarian cancer cell antigens.
| Identifier | MLC-T-ONC-015723 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | OC-PEP-VAC |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015723",
"term": "ovarian cancer peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine comprised of synthetic peptides corresponding to naturally-occurring peptides derived from ovarian cancer cell antigens. Ovarian cancer peptide vaccine may elicit a cytotoxic T-cell response against tumor cells expressing the related ovarian cancer cell antigens.",
"abbreviation": "OC-PEP-VAC",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ovarian-cancer-peptide-vaccine/"
}
Record 12,407 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.